US · Healthcare

Synovics Pharmaceuticals Inc (SYVC)

Biotechnology

Synovics Pharmaceuticals Inc (SYVC) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for SYVC

P/E ratio

25.00

Synovics Pharmaceuticals Inc (SYVC) — FAQ

What is SYVC's P/E ratio?

The price-to-earnings (P/E) ratio for Synovics Pharmaceuticals Inc (SYVC) is 25.00 (data as of 2026-05-23).

Does Synovics Pharmaceuticals Inc pay a dividend?

Dividend yield is not available in the current snapshot for Synovics Pharmaceuticals Inc (SYVC). Check the MyAverix Finance app for the latest dividend data.

What sector is Synovics Pharmaceuticals Inc in?

Synovics Pharmaceuticals Inc (SYVC) is classified in the Healthcare sector (Biotechnology industry).

What exchange is SYVC listed on?

SYVC is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)